Albatha Healthcare Group Expands Diagnostic Capabilities With Milab Scientific Acquisition

Albatha Healthcare Group, a prominent provider of healthcare solutions in the UAE, has broadened its offerings by acquiring Milab Scientific. Milab is renowned for its expertise in medical and laboratory solutions, boasting over 40 years of regional experience.

Dr. Hesham Abdalla, Managing Director at Albatha Healthcare, stated, "This acquisition reflects our commitment to advancing healthcare in the UAE and the region." He emphasized that integrating Milab's expertise will not only bolster their diagnostic capabilities but also drive innovation in scientific solutions. The move aligns with Albatha's long-term growth strategy.

Anis Dadani, Director Finance at Albatha Healthcare, highlighted the strategic nature of this investment. "With Albatha Healthcare's operational scale and market reach, we are well-positioned to integrate Milab's capabilities," he said. The aim is to expand their portfolio in advanced diagnostics and molecular biology while creating sustainable value for stakeholders.

Joshua Marchon, Business Unit Head at Milab Scientific, expressed enthusiasm about joining Albatha Healthcare. "For over four decades, Milab has been driven by quality, service, and innovation," he noted. The partnership allows Milab to extend its legacy by bringing advanced scientific solutions to more healthcare providers across the region.

Milab's expertise spans various fields including molecular biology, genomics, proteomics, haematology, clinical diagnostics, immunohistochemistry, and a wide range of laboratory equipment. This comprehensive knowledge base will be instrumental in enhancing Albatha's service offerings.

The collaboration between Albatha Healthcare and Milab Scientific aims to leverage Albatha's integrated network to accelerate innovation in diagnostics. By expanding access to state-of-the-art laboratory solutions, they intend to empower healthcare providers to deliver improved care efficiently across the region.